title: Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice.
authors.forename: Michael
authors.initials: M
authors.lastname: Cullen
authors.forename: Ala
authors.initials: A
authors.lastname: Szczepura
authors.forename: Michael
authors.initials: M
authors.lastname: Thomas
authors.forename: Adrian
authors.initials: A
authors.lastname: Kielhorn
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003365:Costs and Cost Analysis; D005060:Europe; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic